|
TRIM32 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.642950E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.946200E-01 |
| Normal-vs-Stage2 |
4.947800E-01 |
| Normal-vs-Stage3 |
1.290160E-01 |
| Normal-vs-Stage4 |
1.124570E-03 |
| Stage1-vs-Stage2 |
9.666400E-01 |
| Stage1-vs-Stage3 |
2.754800E-01 |
| Stage1-vs-Stage4 |
4.003500E-03 |
| Stage2-vs-Stage3 |
5.123200E-01 |
| Stage2-vs-Stage4 |
3.241800E-02 |
| Stage3-vs-Stage4 |
7.480400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.625420E-01 |
| Normal-vs-AfricanAmerican |
8.466200E-01 |
| Normal-vs-Asian |
2.583400E-01 |
| Caucasian-vs-AfricanAmerican |
4.382400E-01 |
| Caucasian-vs-Asian |
9.855200E-01 |
| AfricanAmerican-vs-Asian |
4.964800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.925800E-02 |
| Normal-vs-Female |
2.857000E-01 |
| Male-vs-Female |
1.359830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.913800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.151200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.256100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.720000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.119600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.235180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.587400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.471600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.256800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.983000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.101200E-01 |
| Classical-VS-Follicular |
9.667600E-02 |
| Classical-VS-Other |
2.496000E-01 |
| Classical-VS-Normal |
4.792600E-01 |
| Tall-VS-Follicular |
8.975600E-01 |
| Tall-VS-Other |
6.378400E-01 |
| Tall-VS-Normal |
1.033980E-01 |
| Follicular-VS-Other |
6.087800E-01 |
| Follicular-VS-Normal |
8.912000E-02 |
| Other-VS-Normal |
1.346030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.512400E-01 |
| Normal-vs-N1 |
7.984700E-03 |
| N0-vs-N1 |
4.988100E-02 |
|
|
